On May 5, 2021, Governor Ducey signed H.B. 2454, legislation which dramatically expands access to telehealth services in Arizona. The legislation—the most expansive in the country—makes telemedicine a permanent fixture of Arizona’s healthcare system.Continue reading
Category Archives: AZBio News
C-Path Announces Accelerated Data Sharing Collaboration with Tufts Medical Center
FDA Grant Supports Use of Real-World Data to Generate Real-World Evidence in Neonates
TUCSON, Ariz., May 12, 2021 — Critical Path Institute (C-Path) and Tufts Medical Center have announced a joint venture to integrate the first patient-level clinical trial data to generate actionable real-world evidence (RWE) for neonatal drug development, from real-world neonate data (RWD). This activity, funded by a grant from the U.S. Food and Drug Administration (FDA), is being executed through a neonatal pilot project within C-Path’s International Neonatal Consortium (INC). The data sharing collaboration and transfer also marks the fastest on record for C-Path — starting with the Data Contribution Agreement negotiations and receipt of the data in three months’ time this March.Continue reading
Bioscience Startup Wins University of Arizona Center for Innovation Sponsored Launch
TUCSON, Ariz. (May 11, 2021) — The University of Arizona Center for Innovation (UACI) is pleased to announce that uPetsia is the winning startup for the UACI Sponsored Launch Fueled by the Oro Valley Chamber of Commerce competition.
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
- In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
- Data also submitted to European Medicines Agency (EMA) and other global regulators, with additional authorizations expected in coming weeks
Clouds Over the Capitol
TRIPS Waiver, MCIT, HR3. If you are not familiar with these policy developments, you probably should be.
The United States medtech and biotech industries make a tremendous impact on people’s lives. When policy makers and Federal Agencies work together, the impact is made even greater. However, some policy decisions can have the opposite effect.
BIO Extends Agreement with Avantor
Collaboration has evolved for more than two decades
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
Standalone Diabetes Care business expected to leverage position as global leader in insulin delivery and expand presence in large and high-growth diabetes marketContinue reading
Opinion: Now is absolutely not the time to be complacent
In the pandemic’s 17th month, we live in a world of vivid contrast between early-vaccinating countries that appear to be approaching an end to their epidemic and those falling rapidly into the abyss. Brazil and India are suffering escalating COVID caseloads exhausting health care resources. The long haul with the virus in the US and the current situation in Brazil and India have clearly underscored the importance of a strong, coordinated, and sustained public health response.
New undergraduate degree allows students to study neuroscience and the brain
New psychology program is both on campus and online for fall 2021
The Arizona State University Department of Psychology is launching a new on-ground and online Bachelor of Science degree in neuroscience this fall, designed to train the next generation of neuroscientists.
C-Path Appoints Quantitative Sciences Expert as New Sr. Vice President
Dr. Jeff Barrett will lead C-Path’s RDCA-DAP initiative focusing on rare disease data sharing and accelerating therapy development.
TUCSON, Ariz. May 6, 2021 — Critical Path Institute (C-Path) today announced the appointment of Jeff Barrett, Ph.D., F.C.P., as Senior Vice President and lead for its Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) initiative.Continue reading